KP

Kirit Parikh

Active Director Director DIN 07132294
DIN 07132294 First appointment Apr 2015 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Kirit Parikh

Data last updated:

Kirit Parikh is a Director at Ai Di Pharmaceuticals Private Limited (since 2015). The company operates in FMCG. Ai Di Pharmaceuticals Private Limited reported revenue of ₹14.5 Lakh (FY 2024).

DIN 07132294
Primary Designation Director
Industry FMCG
First Appointment 28 Apr 2015
Oldest Company Age 11 yrs
Largest company Ai Di Pharmaceuticals Private Limited · ₹14.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20152015₹14.5 Lakh (FY 2024)Active

Board colleagues of Kirit Parikh

NameDINCompanyDesignation
Vandana Parikh08733851Ai Di Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ai Di Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kirit Parikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kirit Parikh

Kirit Parikh currently holds 1 directorship: Ai Di Pharmaceuticals Private Limited (Director, since 28 Apr 2015, revenue ₹14.5 Lakh (FY 2024)).

Kirit Parikh was first appointed on 28 Apr 2015 as Director at Ai Di Pharmaceuticals Private Limited.

The current boards of Kirit Parikh's companies include Vandana Parikh (Ai Di Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available